OnCore Login

December 2025

Across the Consortium: November/December 2025

December 23, 2025:

In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights the innovation, discovery, and impact happening across our member institutions. From novel therapies to community-focused initiatives, this issue showcases the depth of research that drives progress in cancer prevention, detection, and treatment throughout our member institutions. Read More

Big Ten CRC study, BTCRC-BRE15-024, featured in a poster presentation at the San Antonio Breast Cancer Symposium

December 5, 2025:

A Big Ten Cancer Research Consortium clinical trial, BTCRC-BRE15-024, titled “A phase I/II, single arm, nonrandomized study of ribociclib, a CDK 4/6 inhibitor, in combination with bicalutamide, an androgen receptor inhibitor, in advanced AR-positive triple-negative breast cancer,” (SABCS Poster # PS5-02-26) will be presented by Julia Knight-Shefner, MD, of the University of Wisconsin Carbone Cancer Center, as a poster at the 2025 San Antonio Breast Cancer Symposium. Read More

William P. Harris Joins Big Ten CRC Steering Committee 

November 19, 2025:

The Big Ten Cancer Research Consortium is pleased to announce William P. Harris, MD, as a new member of the Big Ten CRC Steering Committee. Dr. Harris is a board-certified medical oncologist at Fred Hutchinson Cancer Center and UW Medical Center and serves as an associate professor in the Division of Hematology and Oncology at the University of Washington. Read More

Big Ten CRC Study Presented at ESMO 2025 Explores Novel Chemo-Immunotherapy Combination in Small Cell Lung Cancer

December 2, 2025:

A Big Ten CRC clinical trial, BTCRC-LUN18-363, titled, “Chemo-immunotherapy followed by durvalumab and ceralasertib in treatment naïve patients with extensive-stage small cell lung cancer,” led by Muhammad Furqan, MD, formerly of the University of Iowa, was featured as a proffered paper presentation at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin.  Read More

Dr. Gustavo Girotto Joins Big Ten CRC Steering Committee

November 12, 2025

The Big Ten Cancer Research Consortium is pleased to announce Gustavo Girotto, MD, as a new member of the Big Ten CRC Steering Committee. Dr. Girotto is a Clinical Professor of Internal Medicine in Hematology, Oncology, and Blood and Marrow Transplantation at the University of Iowa Holden Comprehensive Cancer Center. Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Maryland

University of Maryland

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Washington

University of Washington

University of Wisconsin

University of Wisconsin

University of Illinois at Chicago

University of Illinois at Chicago

© 2026 All rights reserved.

Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278

email: info@bigtencrc.org    phone: 317–921–2050